Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process
Personalized diets are emerging as a beacon of hope in the complex world of food sensitivity research, offering potential solutions to a pervasive and intricate problem. Food sensitivities, distinct from well-known allergies, are linked to immune responses involving IgA and IgG antibodies. These
In a groundbreaking advancement in cellular biology, scientists at the University of Virginia School of Medicine and the NIH have uncovered a previously unknown organelle, named the hemifusome. This advancement promises profound impacts on understanding and potentially treating complex genetic
The question of whether chromosomal changes can be a catalyst for major evolutionary shifts is becoming increasingly pertinent in contemporary evolutionary biology discourse. Major evolutionary shifts, often referred to as macromutations, describe significant transformations in an organism's
The coffee industry remains a formidable sector in global markets, particularly as new scientific studies highlight potential health benefits related to consumption patterns. As 2025 approaches, coffee continues to be not only a key commodity in international trade but also a significant part of
Drawing from years of experience in biopharmaceutical research and innovation, Ivan Kairatov is known for his insightful contributions to healthcare advancements. With the recent recognition of Tagomics Ltd. through a substantial grant from Innovate UK for colorectal cancer research, Ivan is poised
